Welcome, Guest. Please login or register.

Author Topic: AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes  (Read 1014 times)

0 Members and 1 Guest are viewing this topic.

The Web Team

  • Hero Member
  • *****
  • Posts: 8755
  • Karma: 14
    • View Profile
    • Qwoter
AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
           


<p>Company to Host Conference Call and Webcast on July 31, 2008 at 9 a.m. EDT</p>
           

http://www.marketwire.com/mw/release.do?id=884633&sourceType=3
           
The Web Team
Qwoter.com

Tags:
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
938 Views
Last post October 23, 2007, 09:00:33 AM
by The Web Team
0 Replies
819 Views
Last post February 01, 2008, 09:01:05 AM
by The Web Team
0 Replies
1011 Views
Last post February 07, 2008, 07:00:51 AM
by The Web Team
0 Replies
968 Views
Last post February 26, 2008, 09:00:55 AM
by The Web Team
0 Replies
1034 Views
Last post April 14, 2008, 06:00:35 AM
by The Web Team
0 Replies
1068 Views
Last post May 13, 2008, 10:52:15 AM
by The Web Team
0 Replies
1018 Views
Last post July 08, 2008, 03:08:38 PM
by The Web Team
0 Replies
1136 Views
Last post July 14, 2008, 03:10:46 PM
by The Web Team
0 Replies
1341 Views
Last post February 09, 2009, 01:01:24 AM
by Stock Spam
0 Replies
486 Views
Last post March 12, 2014, 07:10:14 PM
by MTnews